NYXH Nyxoah

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares



REGULATED INFORMATION

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), March 31, 2023, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.

  •  Share capital: EUR 4,859,382.45 
  •  Total number of securities carrying voting rights: 28,286,985 (all ordinary shares) 
  •  Total number of voting rights (= denominator): 28,286,985 (all relating to ordinary shares)  
  •  Number of rights to subscribe to securities carrying voting rights not yet issued: 
    •  55 “2016 ESOP Warrants” issued on November 3, 2016, entitling their holders to subscribe to a total number of 27,500 securities carrying voting rights (all ordinary shares); 
    •  100 “2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 50,000 securities carrying voting rights (all ordinary shares);  
    •  430,500 “2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of 430,500 securities carrying voting rights (all ordinary shares); and
    •  1,326,375 “2021 ESOP Warrants” issued on September 8, 2021, entitling their holders to subscribe to a total number of 1,326,375 securities carrying voting rights (all ordinary shares); and
    •  700,000 “2022 ESOP Warrants” issued on December 28, 2022, entitling their holders to subscribe to a total number of 700,000 securities carrying voting rights (all ordinary shares).  

*

*        *

Contacts:

Nyxoah

David DeMartino, Chief Strategy Officer





Attachment



EN
31/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nyxoah

 PRESS RELEASE

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® ...

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorizations, and Widespread Payor Coverage Mont-Saint-Guibert, Belgium – October 6, 2025 7:00 CET / 1:00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that the first U.S. commercial patients have been successfully implanted with...

 PRESS RELEASE

Nyxoah Annonce les Premiers Patients Commerciaux Aux États-Unis Implan...

Nyxoah Annonce les Premiers Patients Commerciaux Aux États-Unis Implantés avec le Système Genio® Nyxoah Annonce les Premiers Patients Commerciaux Aux États-Unis Implantés avec le Système Genio® Le lancement commercial initial témoigne d'une forte demande de la part des médecins, de préautorisations concluantes et d'une couverture étendue par les payeurs Mont-Saint-Guibert, Belgique – 6 octobre 2025, 7h00 CET / 1h10 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale développant des alternatives thérapeutiques révolutionnaires...

 PRESS RELEASE

Publication relating to transparency notifications

Publication relating to transparency notifications REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 3, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. Vestal Point Capital On October 1, 2025, Nyxoah received a transparency notification from Vestal Point Capital following an acquisition or disposal of voting securities or voting r...

 PRESS RELEASE

Publication relative à des notifications de transparence

Publication relative à des notifications de transparence         INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 3 octobre 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels/Nasdaq : NYXH) annonce qu’elle a reçu une notification de transparence comme détaillée ci-dessous. Vestal Point Capital Le 1er octobre 2025, Nyxoah a reçu une notification de transparence de Vestal Point Capital suite à une acquisitio...

 PRESS RELEASE

Nyxoah Provides an Update on Expanded Middle East Presence

Nyxoah Provides an Update on Expanded Middle East Presence Nyxoah Provides an Update on Expanded Middle East Presence New Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Implant in the Region Earlier in 2025 Mont-Saint-Guibert, Belgium – September 23, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced the continued expansion of its commercial footprint in the Middle East, following the first successful Genio® implant in A...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch